BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 18550747)

  • 21. Use of 16S rRNA gene sequencing for identification of nonfermenting gram-negative bacilli recovered from patients attending a single cystic fibrosis center.
    Ferroni A; Sermet-Gaudelus I; Abachin E; Quesne G; Lenoir G; Berche P; Gaillard JL
    J Clin Microbiol; 2002 Oct; 40(10):3793-7. PubMed ID: 12354883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex.
    Henry DA; Mahenthiralingam E; Vandamme P; Coenye T; Speert DP
    J Clin Microbiol; 2001 Mar; 39(3):1073-8. PubMed ID: 11230429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved molecular detection of Burkholderia cepacia genomovar III and Burkholderia multivorans directly from sputum of patients with cystic fibrosis.
    Moore JE; Xu J; Millar BC; Crowe M; Elborn JS
    J Microbiol Methods; 2002 Apr; 49(2):183-91. PubMed ID: 11830304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of lysine positive non-fermenting gram negative bacilli (Stenotrophomonas maltophilia and Burkholderia cepacia complex).
    Gautam V; Ray P; Vandamme P; Chatterjee SS; Das A; Sharma K; Rana S; Garg RK; Madhup SK; Mahajan M; Sharma M
    Indian J Med Microbiol; 2009; 27(2):128-33. PubMed ID: 19384035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov.
    Vanlaere E; Baldwin A; Gevers D; Henry D; De Brandt E; LiPuma JJ; Mahenthiralingam E; Speert DP; Dowson C; Vandamme P
    Int J Syst Evol Microbiol; 2009 Jan; 59(Pt 1):102-11. PubMed ID: 19126732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymerase chain reaction for the detection of Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia in sputum of patients with cystic fibrosis.
    Karpati F; Jonasson J
    Mol Cell Probes; 1996 Dec; 10(6):397-403. PubMed ID: 9025076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Isolation and identification of Burkholderia cepacia complex from cystic fibrosis patients].
    Yurdakul P; Ergünay K; Yalçin E; Doğru D; Sener B; Cobanoğlu N; Ozçelik U; Kiper N
    Mikrobiyol Bul; 2006 Oct; 40(4):301-6. PubMed ID: 17205687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections.
    Heirali A; McKeon S; Purighalla S; Storey DG; Rossi L; Costilhes G; Drews SJ; Rabin HR; Surette MG; Parkins MD
    PLoS One; 2016; 11(2):e0148534. PubMed ID: 26859493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients.
    Coenye T; LiPuma JJ; Henry D; Hoste B; Vandemeulebroecke K; Gillis M; Speert DP; Vandamme P
    Int J Syst Evol Microbiol; 2001 Mar; 51(Pt 2):271-9. PubMed ID: 11321071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Burkholderia cepacia complex: distribution of genomovars among isolates from the maize rhizosphere in Italy.
    Fiore A; Laevens S; Bevivino A; Dalmastri C; Tabacchioni S; Vandamme P; Chiarini L
    Environ Microbiol; 2001 Feb; 3(2):137-43. PubMed ID: 11321544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Burkholderia cepacia complex epidemiology in persons with cystic fibrosis from Australia and New Zealand.
    Kidd TJ; Douglas JM; Bergh HA; Coulter C; Bell SC
    Res Microbiol; 2008 Apr; 159(3):194-9. PubMed ID: 18356026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Pseudomonas aeruginosa, Burkholderia cepacia complex, and Stenotrophomonas maltophilia in respiratory samples from cystic fibrosis patients using multiplex PCR.
    da Silva Filho LV; Tateno AF; Velloso Lde F; Levi JE; Fernandes S; Bento CN; Rodrigues JC; Ramos SR
    Pediatr Pulmonol; 2004 Jun; 37(6):537-47. PubMed ID: 15114555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and onion pathogenicity of Burkholderia cepacia complex isolates from the onion rhizosphere and onion field soil.
    Jacobs JL; Fasi AC; Ramette A; Smith JJ; Hammerschmidt R; Sundin GW
    Appl Environ Microbiol; 2008 May; 74(10):3121-9. PubMed ID: 18344334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Burkholderia puraquae sp. nov., a novel species of the Burkholderia cepacia complex isolated from hospital settings and agricultural soils.
    Martina P; Leguizamon M; Prieto CI; Sousa SA; Montanaro P; Draghi WO; Stämmler M; Bettiol M; de Carvalho CCCR; Palau J; Figoli C; Alvarez F; Benetti S; Lejona S; Vescina C; Ferreras J; Lasch P; Lagares A; Zorreguieta A; Leitão JH; Yantorno OM; Bosch A
    Int J Syst Evol Microbiol; 2018 Jan; 68(1):14-20. PubMed ID: 29095137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis.
    Kiska DL; Kerr A; Jones MC; Caracciolo JA; Eskridge B; Jordan M; Miller S; Hughes D; King N; Gilligan PH
    J Clin Microbiol; 1996 Apr; 34(4):886-91. PubMed ID: 8815102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polyphasic characterisation of Burkholderia cepaciacomplex species isolated from children with cystic fibrosis.
    Vicenzi FJ; Pillonetto M; Souza HA; Palmeiro JK; Riedi CA; Rosario-Filho NA; Dalla-Costa LM
    Mem Inst Oswaldo Cruz; 2016 Jan; 111(1):37-42. PubMed ID: 26814642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients.
    van Belkum A; Renders NH; Smith S; Overbeek SE; Verbrugh HA
    FEMS Immunol Med Microbiol; 2000 Jan; 27(1):51-7. PubMed ID: 10617790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fourier Transform Infrared Spectroscopy for Typing Burkholderia cenocepacia ET12 Isolates.
    Barker KR; Santino M; LiPuma JJ; Tullis E; Muller MP; Matukas LM; Tadros M
    Microbiol Spectr; 2021 Dec; 9(3):e0183121. PubMed ID: 34878338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients.
    De Boeck K; Malfroot A; Van Schil L; Lebecque P; Knoop C; Govan JR; Doherty C; Laevens S; Vandamme P;
    Eur Respir J; 2004 Jun; 23(6):851-6. PubMed ID: 15218997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients.
    LiPuma JJ; Dulaney BJ; McMenamin JD; Whitby PW; Stull TL; Coenye T; Vandamme P
    J Clin Microbiol; 1999 Oct; 37(10):3167-70. PubMed ID: 10488171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.